Hologic, Inc.
HOLX · NASDAQ
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/28/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 2.5% | 1.8% | -1.6% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $0 |
| Gross Profit | $1 | $1 | $0 | $1 |
| % Margin | 60.9% | 56.3% | 37.5% | 56.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | -$0 | $0 |
| % Margin | 22.6% | 24.9% | -0.7% | 22.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $0 | $0 | -$0 | $0 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 17.8% | 19% | -1.7% | 19.7% |
| EPS | 0.84 | 0.87 | -0.08 | 0.87 |
| % Growth | -3.4% | 1,187.5% | -109.2% | – |
| EPS Diluted | 0.83 | 0.86 | -0.08 | 0.87 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 30.2% | 32.6% | 7.6% | 34.4% |